Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)

Launched by DANA-FARBER CANCER INSTITUTE · Jun 17, 2024

Keywords

ClinConnect Summary

The DIVERSE clinical trial is focused on improving the inclusion and diversity of people participating in clinical trials for blood cancer, specifically leukemia. The study aims to train participants to review research protocols and provide feedback, ensuring that a wider range of voices and experiences is included in medical research. This is important because having diverse participants can lead to better understanding and treatments for everyone affected by these conditions.

To be eligible for this trial, participants need to be at least 18 years old, able to speak English, and willing to provide their consent. Ideally, participants will be patients who have been in remission from blood cancer for more than a year. The trial is currently recruiting, and anyone interested should know that participation involves reviewing and discussing clinical trial materials, helping to make research more inclusive. It’s a unique opportunity to contribute to important medical research while sharing your insights and experiences.

Gender

ALL

Eligibility criteria

• CAB Participant Inclusion Criteria:
• • Age 18 or older
• • English speaking
• • Ability to understand and willingness to provide oral consent
• • DFCI patient who are in remission from a blood cancer \>1 year will be preferred.
• CAB Participant Exclusion Criteria:
• • Adults unable to consent
• • Individuals who are not yet adults (infants, children, teenagers \<18 years old)
• • Prisoners.
• • Unwilling/unable to agree to maintaining the confidentiality of reviews and clinical trial materials, as outlined in Section 9.1
• • Note 1: Patients and non-patient community members who are pregnant are eligible. This is a non-interventional study that meets the definition of minimal risk and poses no greater risk to pregnant individuals or fetuses. Pregnancy status will not be assessed.
• • Note 2: English fluency is necessary as protocols being reviewed are written in English and cannot be feasibly translated to other languages within the time period necessary to complete timely reviews.
• Investigator Participant Inclusion Criteria:
• • Age 18 older
• • English Speaking
• • Site or Principal investigator
• • Not a member of the research team